Literature DB >> 28064232

Primary Vaginal Melanoma, A Rare and Aggressive Entity. A Case Report and Review of the Literature.

Emmanouil Kalampokas1, Theodoros Kalampokas2, Christos Damaskos3,4.   

Abstract

Malignant melanoma of the vagina is a rare, aggressive malignancy of poor prognosis. It principally affects post-menopausal women, with a mean age of 57 years, and the factors that contribute to its appearance are not well known. The first case of primary malignant vaginal melanoma was reported in 1887 and modern literature has noted about 500 cases, globally. Vaginal melanomas constitute 0.3% of all malignant melanomas and fewer than 3% of all vaginal carcinomas. To date there is no clear consensus regarding treatment. An early, accurate diagnosis and prompt investigation is essential in reaching appropriate treatment decisions. We present a clinical case of primary vaginal melanoma and review the literature briefly, presenting the current treatment plans and updates of this rare gynecological malignancy. Considerations, epidemiology, associated risk factors, response to therapy and expected outcome are also discussed.
CONCLUSION: Primary malignant vaginal melanoma is a rare but aggressive melanoma that affects women in their 6th and 7th decade of life. The tumor appears as a dark node or spindle but can also be amelanotic. The size of the tumor is indicative of the prognostic factors. Surgery seems to be the only efficient treatment. Postoperative adjuvant therapy might help in preventing recurrence of the tumor. The survival rate is largely dependent on nodal and distant metastasis of the disease after initial tumor resection. There is a dire need to form a proper therapeutic regime to control this disease. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Primary; excision; melanoma; prognosis; staging; treatment; vaginal

Mesh:

Year:  2017        PMID: 28064232      PMCID: PMC5354139          DOI: 10.21873/invivo.11036

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  33 in total

1.  Treatment of locally recurrent mucosal melanoma with topical imiquimod.

Authors:  Elizabeth C Smyth; Marisa Flavin; Melissa P Pulitzer; Ginger J Gardner; Peter D Costantino; Dennis S Chi; Kita Bogatch; Paul B Chapman; Jedd D Wolchok; Gary K Schwartz; Richard D Carvajal
Journal:  J Clin Oncol       Date:  2011-10-17       Impact factor: 44.544

2.  Primary Malignant Vaginal Melanoma - Case Report and Review of the Literature.

Authors:  F Kühn; M Dieterich; E Klar; B Gerber; C Prinz
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-08       Impact factor: 2.915

3.  Primary melanoma of the vagina: a case report.

Authors:  S Samolis; P Panagopoulos; N Kanellopoulos; I Papastefanou; S Karadaglis; M Katsoulis
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

4.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

5.  Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas.

Authors:  Dan-Ning Hu; Guo-Pei Yu; Steven A McCormick
Journal:  Melanoma Res       Date:  2010-04       Impact factor: 3.599

6.  Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.

Authors:  Susan Seifried; Lauren E Haydu; Michael J Quinn; Richard A Scolyer; Jonathan R Stretch; John F Thompson
Journal:  Ann Surg Oncol       Date:  2014-11-11       Impact factor: 5.344

Review 7.  Primary malignant melanoma of the vagina: a case report and review of the current treatment options.

Authors:  Hüsnü Gökaslan; Alper Sişmanoğlu; Tanju Pekin; Handan Kaya; Nejat Ceyhan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-08-01       Impact factor: 2.435

8.  Somatic activation of KIT in distinct subtypes of melanoma.

Authors:  John A Curtin; Klaus Busam; Daniel Pinkel; Boris C Bastian
Journal:  J Clin Oncol       Date:  2006-08-14       Impact factor: 44.544

9.  KIT gene mutations and copy number in melanoma subtypes.

Authors:  Carol Beadling; Erick Jacobson-Dunlop; F Stephen Hodi; Claudia Le; Andrea Warrick; Janice Patterson; Ajia Town; Amy Harlow; Frank Cruz; Sharl Azar; Brian P Rubin; Susan Muller; Rob West; Michael C Heinrich; Christopher L Corless
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

10.  Treatment approach and outcomes of vaginal melanoma.

Authors:  Austin N Kirschner; Elizabeth A Kidd; Todd Dewees; Stephanie M Perkins
Journal:  Int J Gynecol Cancer       Date:  2013-10       Impact factor: 3.437

View more
  4 in total

1.  Female genital tract melanoma: Analysis from a regional cancer institute.

Authors:  Garima Pandey; Pariseema Dave; Shilpa Patel; Bijal Patel; Ruchi Arora; Chetna Parekh; Dimpy Begum
Journal:  Turk J Obstet Gynecol       Date:  2020-04-06

2.  Malignant nodular melanoma of the vulva: a rare and aggressive tumour of the female genital tract (case report).

Authors:  Moshawa Calvin Khaba; Matsiane Luciah Lekala; Setheme Daniel Mosehle
Journal:  Pan Afr Med J       Date:  2021-02-03

3.  Primary Vaginal Amelanotic Melanoma: A Diagnostic Conundrum.

Authors:  Purwa Patil; Wasif Ali Khan; Vaishali Walke; Ketaki Patil
Journal:  Cureus       Date:  2021-12-29

Review 4.  Vulvar and Vaginal Melanomas-The Darker Shades of Gynecological Cancers.

Authors:  Elena-Codruța Dobrică; Cristina Vâjâitu; Carmen Elena Condrat; Dragoș Crețoiu; Ileana Popa; Bogdan Severus Gaspar; Nicolae Suciu; Sanda Maria Crețoiu; Valentin Nicolae Varlas
Journal:  Biomedicines       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.